Literature DB >> 30043863

VISCERAL FAT IS INCREASED IN INDIVIDUALS WITH CROHN'S DISEASE: A COMPARATIVE ANALYSIS WITH HEALTHY CONTROLS.

Daniéla Oliveira Magro1, Maria Rita Lazzarini Barreto1, Everton Cazzo1, Michel Gardere Camargo1, Paulo Gustavo Kotze2, Claudio Saddy Rodrigues Coy1.   

Abstract

BACKGROUND: It is known that obesity is associated with a chronic inflammatory state, but few studies have evaluated visceral fat (VF) content and its role in individuals with Crohn's disease (CD). OBJETIVE: To compare the nutritional status, body composition and proportion of VF between CD individuals and healthy volunteers.
METHODS: Cross-sectional study that enrolled individuals with Crohn's disease and healthy controls. The stratification according to nutritional status was carried out by means of BMI. The percentage of body fat percentage (%BF) and VF were estimated by means of DEXA. VF proportion was evaluated by means of the VF/BMI and VF/%BF ratios.
RESULTS: A total of 78 individuals were included. The control group was comprised of 28 healthy subjects aged 35.39±10 years old (60.7% women); mean BMI=23.94±3.34 kg/m2; mean VF=511.82±448.68 g; mean CRP=0.81±1.78 ng/mL. The CD group was comprised of 50 patients; 11 (22%) were underweight (BMI=18.20±1.97 kg/ m2; %BF=24.46±10.01; VF=217.18±218.95 g; CRP=4.12±4.84 ng/mL); 18 (36%) presented normal weight (BMI=22.43±1.48 kg/m2; %BF=30.92±6.63; VF=542.00±425.47 g and CRP=4.40±1.78 ng/mL); 21 (42%) were overweight or obese (BMI=29.48±3.78 kg/m2; %BF=39.91±7.33; VF=1525.23±672.7 g and CRP=1.33±2.06 ng/mL). The VF/BMI ratio was higher in the CD group when compared to controls (32.41±24.63 vs 20.01±16.23 g per BMI point; P=0.02). Likewise, the VF/%BF was also higher in the CD group (35.21±23.33 vs 15.60±12.55 g per percentage point; P<0.001).
CONCLUSION: Among individuals with Crohn's disease, BMI presents a direct correlation with visceral fat content. These results indicate the presence of an adiposopathy in Crohn's disease subjects, which is evidenced by a higher visceral fat.

Entities:  

Mesh:

Year:  2018        PMID: 30043863     DOI: 10.1590/S0004-2803.201800000-25

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  5 in total

1.  Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease.

Authors:  Nik Sheng Ding; Daniel Tassone; Ibrahim Al Bakir; Kyle Wu; Alexander J Thompson; William R Connell; George Malietzis; Phillip Lung; Siddharth Singh; Chang-Ho Ryan Choi; Simon Gabe; John T Jenkins; Ailsa Hart
Journal:  J Crohns Colitis       Date:  2022-09-08       Impact factor: 10.020

2.  Nutritional Global Status and Its Impact in Crohn's Disease.

Authors:  Juliana Midori Iqueda Prieto; Adriana Ribas Andrade; Daniela Oliveira Magro; Marcello Imbrizi; Iêda Nishitokukado; Carmen Lucia Ortiz-Agostinho; Fabiana Maria Dos Santos; Liania Alves Luzia; Patricia Helen de Carvalho Rondo; André Zonetti de Arruda Leite; Flair José Carrilho; Aytan Miranda Sipahi
Journal:  J Can Assoc Gastroenterol       Date:  2021-03-23

3.  Adults with Crohn's disease exhibit elevated gynoid fat and reduced android fat irrespective of disease relapse or remission.

Authors:  Lisa Dowling; Philip Jakeman; Catherine Norton; Maeve M Skelly; Hamid Yousuf; Miranda G Kiernan; Margaret Toomey; Sheila Bowers; Suzanne S Dunne; J Calvin Coffey; Colum P Dunne
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

Review 4.  The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders.

Authors:  Maafi R Islam; Subha Arthur; Jennifer Haynes; Molly R Butts; Niraj Nepal; Uma Sundaram
Journal:  Nutrients       Date:  2022-01-31       Impact factor: 5.717

5.  Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.

Authors:  Peter Meisel; Stefanie Pagels; Markus Grube; Gabriele Jedlitschky; Henry Völzke; Thomas Kocher
Journal:  Clin Oral Investig       Date:  2020-09-22       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.